These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35666698)

  • 1. Association of ST2 Elevation in the Early Third Trimester with Heart Failure and Pre-Eclampsia in the Peripartum Period.
    Kim H; Kim IC; Bae JG; Lee HJ; Park JH; Song JE
    J Womens Health (Larchmt); 2022 Nov; 31(11):1587-1595. PubMed ID: 35666698
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic Value of Serial ST2 Measurements in Patients With Acute Heart Failure.
    van Vark LC; Lesman-Leegte I; Baart SJ; Postmus D; Pinto YM; Orsel JG; Westenbrink BD; Brunner-la Rocca HP; van Miltenburg AJM; Boersma E; Hillege HL; Akkerhuis KM;
    J Am Coll Cardiol; 2017 Nov; 70(19):2378-2388. PubMed ID: 29096809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating systemic fibrosis by combining galectin-3 and ST2 provides powerful risk stratification value for patients after acute decompensated heart failure.
    Wang CH; Yang NI; Liu MH; Hsu KH; Kuo LT
    Cardiol J; 2016; 23(5):563-572. PubMed ID: 27515479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTproBNP and ST2 as predictors for all-cause and cardiovascular mortality in elderly patients with symptoms suggestive for heart failure.
    Boman K; Thormark Fröst F; Bergman AR; Olofsson M
    Biomarkers; 2018; 23(4):373-379. PubMed ID: 29355441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble ST2 in ambulatory patients with heart failure: Association with functional capacity and long-term outcomes.
    Felker GM; Fiuzat M; Thompson V; Shaw LK; Neely ML; Adams KF; Whellan DJ; Donahue MP; Ahmad T; Kitzman DW; Piña IL; Zannad F; Kraus WE; O'Connor CM
    Circ Heart Fail; 2013 Nov; 6(6):1172-9. PubMed ID: 24103327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ST2 elevation in heart failure, predictive of a high early mortality.
    Dalal JJ; Digrajkar A; Das B; Bansal M; Toomu A; Maisel AS
    Indian Heart J; 2018; 70(6):822-827. PubMed ID: 30580851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The correlation between maternal serum sST2, IL-33 and NT-proBNP concentrations and occurrence of pre-eclampsia in twin pregnancies: A longitudinal study.
    Xiang Q; Chen Y; Gu X; Yang Y; Wang Y; Zhao Y
    J Clin Hypertens (Greenwich); 2022 Nov; 24(11):1516-1523. PubMed ID: 36149818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of diabetes on the predictive value of heart failure biomarkers.
    Alonso N; Lupón J; Barallat J; de Antonio M; Domingo M; Zamora E; Moliner P; Galán A; Santesmases J; Pastor C; Mauricio D; Bayes-Genis A
    Cardiovasc Diabetol; 2016 Nov; 15(1):151. PubMed ID: 27809845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-specific cut-off values for soluble suppression of tumorigenicity 2 (ST2) biomarker increase its cardiovascular prognostic value in the community.
    Harmon DM; AbouEzzeddine OF; McKie PM; Scott CG; Saenger AK; Jaffe AS
    Biomarkers; 2021 Nov; 26(7):639-646. PubMed ID: 34269635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pre-eclampsia-eclampsia on major cardiovascular events among peripartum women in Taiwan.
    Lin YS; Tang CH; Yang CY; Wu LS; Hung ST; Hwa HL; Chu PH
    Am J Cardiol; 2011 Jan; 107(2):325-30. PubMed ID: 21211611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart failure in pregnant women with cardiac disease: data from the ROPAC.
    Ruys TP; Roos-Hesselink JW; Hall R; Subirana-Domènech MT; Grando-Ting J; Estensen M; Crepaz R; Fesslova V; Gurvitz M; De Backer J; Johnson MR; Pieper PG
    Heart; 2014 Feb; 100(3):231-8. PubMed ID: 24293523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First trimester placental retinol-binding protein 4 (RBP4) and pregnancy-associated placental protein A (PAPP-A) in the prediction of early-onset severe pre-eclampsia.
    Yliniemi A; Nurkkala MM; Kopman S; Korpimaki T; Kouru H; Ryynanen M; Marttala J
    Metabolism; 2015 Apr; 64(4):521-6. PubMed ID: 25633269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ST2 pathogenetic profile in ambulatory heart failure patients.
    Bayes-Genis A; Januzzi JL; Gaggin HK; de Antonio M; Motiwala SR; Zamora E; Galán A; Domingo M; Urrutia A; Lupón J
    J Card Fail; 2015 Apr; 21(4):355-61. PubMed ID: 25451702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure to up-regulate VEGF165b in maternal plasma is a first trimester predictive marker for pre-eclampsia.
    Bills VL; Varet J; Millar A; Harper SJ; Soothill PW; Bates DO
    Clin Sci (Lond); 2009 Feb; 116(3):265-72. PubMed ID: 18826376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum ST2 and hospitalization rates in Caucasian and African American outpatients with heart failure.
    Savvoulidis P; Snider JV; Rawal S; Morris AA; Butler J; Georgiopoulou VV; Kalogeropoulos AP
    Int J Cardiol; 2020 Apr; 304():116-121. PubMed ID: 31706624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers of heart failure in pleural fluid.
    Porcel JM; Martínez-Alonso M; Cao G; Bielsa S; Sopena A; Esquerda A
    Chest; 2009 Sep; 136(3):671-677. PubMed ID: 19363209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ST2 and IL-33 in pregnancy and pre-eclampsia.
    Granne I; Southcombe JH; Snider JV; Tannetta DS; Child T; Redman CW; Sargent IL
    PLoS One; 2011; 6(9):e24463. PubMed ID: 21949719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Spectrum of Pregnancy-Associated Heart Failure Phenotypes: An Echocardiographic Study.
    Lindley KJ; Williams D; Conner SN; Verma A; Cahill AG; Davila-Roman VG
    Int J Cardiovasc Imaging; 2020 Sep; 36(9):1637-1645. PubMed ID: 32377913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of plasma cell-free DNA and ST2 as parameters in gestational hypertension and preeclampsia.
    Liu L; Li H; Wang N; Song X; Zhao K; Zhang C
    Hypertens Res; 2021 Aug; 44(8):996-1001. PubMed ID: 33864012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.